Introduction: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally, characterized by airflow limitation and lung hyperinflation due to emphysema. Bronchoscopic lung volume reduction (BLVR) with endobronchial valves offers a minimally invasive treatment option for emphysema, aiming to reduce lung hyperinflation, thereby improving lung function and exercise tolerance. Methods: This study evaluated the efficacy of BLVR in a real-life nationwide setting using comprehensive Danish registries. The study population included patients who underwent BLVR between January 1, 2013, and December 31, 2021. We assessed clinical outcomes, including forced expiratory volume in 1 s (FEV1), Medical Research Council (MRC) dyspnea score, and the rates of exacerbations and pneumonia before and after the procedure. A control cohort of matched COPD patients was also analyzed. Results: Following BLVR, a significant increase in FEV1, similar to the improvements reported in randomized controlled trials, was observed. Additionally, the proportion of patients classified as GOLD stage IV decreased from 71.3% to 60.6% after BLVR. The incidence rate ratio for severe exacerbations significantly dropped to 0.56 (95% confidence interval 0.47–0.67, p < 0.01) after BLVR. No significant changes were observed in the rates of moderate and severe pneumonia, and mortality rates did not differ significantly from those in the matched control cohort. Conclusion: This study demonstrates the real-life efficacy of BLVR using endobronchial valves, highlighting a significant improvement in FEV1 and a reduction in severe COPD exacerbations. The procedure did not increase pneumonia rates or affect mortality, supporting continued use of BLVR for managing patients with COPD.

1.
Ruvuna
L
,
Sood
A
.
Epidemiology of chronic obstructive pulmonary disease
.
Clin Chest Med
.
2020
;
41
(
3
):
315
27
.
2.
Ferguson
GT
.
Why does the lung hyperinflate
.
Proc Am Thorac Soc
.
2006
;
3
(
2
):
176
9
.
3.
Miravitlles
M
,
Ribera
A
.
Understanding the impact of symptoms on the burden of COPD
.
Respir Res
.
2017
;
18
(
1
):
67
.
4.
Venkatesan
P
.
GOLD COPD report: 2024 update
.
Lancet Respir Med
.
2024
;
12
(
1
):
15
6
.
5.
Fishman
A
,
Martinez
F
,
Naunheim
K
,
Piantadosi
S
,
Wise
R
,
Ries
A
, et al
.
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
.
N Engl J Med
.
2003
;
348
(
21
):
2059
73
.
6.
Whittaker
HR
,
Connell
O
,
Campbell
J
,
Elbehairy
AF
,
Hopkinson
NS
,
Quint
JK
.
Eligibility for lung volume reduction surgery in patients with COPD identified in a UK primary care setting
.
Chest
.
2020
;
157
(
2
):
276
85
.
7.
Posthuma
R
,
Vaes
AW
,
Spruit
MA
,
Vanfleteren
LEGW
.
Recent advances in bronchoscopic lung volume reduction for severe COPD patients
.
Curr Opin Support Palliat Care
.
2023
;
17
(
4
):
296
300
.
8.
De Oliveira
HG
,
De Oliveira
SM
,
Rambo
RR
,
De Macedo Neto
AV
.
Fissure integrity and volume reduction in emphysema: a retrospective study
.
Respiration
.
2016
;
91
(
6
):
471
9
.
9.
Criner
GJ
,
Sue
R
,
Wright
S
,
Dransfield
M
,
Rivas-Perez
H
,
Wiese
T
, et al
.
A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE)
.
Am J Respir Crit Care Med
.
2018
;
198
(
9
):
1151
64
.
10.
Sciurba
FC
,
Ernst
A
,
Herth
FJF
,
Strange
C
,
Criner
GJ
,
Marquette
CH
, et al
.
A randomized study of endobronchial valves for advanced emphysema
.
N Engl J Med
.
2010
;
363
(
13
):
1233
44
.
11.
Wood
DE
,
McKenna
RJ
,
Yusen
RD
,
Sterman
DH
,
Ost
DE
,
Springmeyer
SC
, et al
.
A multicenter trial of an intrabronchial valve for treatment of severe emphysema
.
J Thorac Cardiovasc Surg
.
2007
;
133
(
1
):
65
73
.
12.
Low
SW
,
Swanson
KL
,
Lee
JZ
,
Tan
MC
,
Cartin-Ceba
R
,
Sakata
KK
, et al
.
Complications of endobronchial valve placement for bronchoscopic lung volume reduction: insights from the food and drug administration manufacturer and user facility device experience (MAUDE)
.
J Bronchol Interv Pulmonol
.
2022
;
29
(
3
):
206
12
.
13.
Patel
M
,
Chowdhury
J
,
Zhao
H
,
Lu
X
,
Roth
S
,
Giovacchini
CX
, et al
.
Meta-analysis and systematic review of bronchoscopic lung volume reduction through endobronchial valves in severe emphysema
.
J Bronchol Interv Pulmonol
.
2022
;
29
(
3
):
224
37
.
14.
Wang
Y
,
Lai
TW
,
Xu
F
,
Zhou
JS
,
Li
ZY
,
Xu
XC
, et al
.
Efficacy and safety of bronchoscopic lung volume reduction therapy in patients with severe emphysema: a meta-analysis of randomized controlled trials
.
Oncotarget
.
2017
;
8
(
44
):
78031
43
.
15.
Pedersen
CB
.
The Danish Civil registration system
.
Scand J Public Health
.
2011
;
39
(
7 Suppl l
):
22
5
.
16.
Schmidt
M
,
Schmidt
SAJ
,
Sandegaard
JL
,
Ehrenstein
V
,
Pedersen
L
,
Sørensen
HT
.
The Danish National Patient Registry: a review of content, data quality, and research potential
.
Clin Epidemiol
.
2015
;
449
:
449
.
17.
Pottegård
A
,
Schmidt
SAJ
,
Wallach-Kildemoes
H
,
Sørensen
HT
,
Hallas
J
,
Schmidt
M
.
Data resource profile: the Danish National prescription registry
.
Int J Epidemiol
.
2017
;
46
(
3
):
798
f
.
18.
Lange
P
,
Tøttenborg
S
,
Sorknæs
A
,
Andersen
J
,
Søgaard
M
,
Nielsen
H
, et al
.
Danish Register of chronic obstructive pulmonary disease
.
Clin Epidemiol
.
2016
;
8
:
673
8
.
19.
World Health Organization
.
The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research
.
World Health Organization
;
1993
.
20.
Munari
AB
,
Gulart
AA
,
Araújo
J
,
Zanotto
J
,
Sagrillo
LM
,
Karloh
M
, et al
.
Modified medical research Council and COPD assessment test cutoff points
.
Respir Care
.
2021
;
66
(
12
):
1876
84
.
21.
Quan
H
,
Li
B
,
Couris
CM
,
Fushimi
K
,
Graham
P
,
Hider
P
, et al
.
Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries
.
Am J Epidemiol
.
2011
;
173
(
6
):
676
82
.
22.
Herth
FJF
,
Noppen
M
,
Valipour
A
,
Leroy
S
,
Vergnon
JM
,
Ficker
JH
, et al
.
Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort
.
Eur Respir J
.
2012
;
39
(
6
):
1334
42
.
23.
Kemp
SV
,
Slebos
DJ
,
Kirk
A
,
Kornaszewska
M
,
Carron
K
,
Ek
L
, et al
.
A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM)
.
Am J Respir Crit Care Med
.
2017
;
196
(
12
):
1535
43
.
24.
Valipour
A
,
Slebos
DJ
,
Herth
F
,
Darwiche
K
,
Wagner
M
,
Ficker
JH
, et al
.
Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study
.
Am J Respir Crit Care Med
.
2016
;
194
(
9
):
1073
82
.
25.
Rebelo
P
,
Oliveira
A
,
Andrade
L
,
Valente
C
,
Marques
A
.
Minimal clinically important differences for patient-reported outcome measures of fatigue in patients with COPD following pulmonary rehabilitation
.
Chest
.
2020
;
158
(
2
):
550
61
.
26.
Koster
TD
,
Shah
PL
,
Valipour
A
,
Criner
GJ
,
Herth
FJF
,
Sue
R
, et al
.
Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves
.
Respir Med
.
2024
;
227
:
107639
.
27.
Klooster
K
,
Ten Hacken
NHT
,
Hartman
JE
,
Kerstjens
HAM
,
Van Rikxoort
EM
,
Slebos
DJ
.
Endobronchial valves for emphysema without interlobar collateral ventilation
.
N Engl J Med
.
2015
;
373
(
24
):
2325
35
.
28.
Ingenito
EP
,
Wood
DE
,
Utz
JP
.
Bronchoscopic lung volume reduction in severe emphysema
.
Proc Am Thorac Soc
.
2008
;
5
(
4
):
454
60
.
29.
Brock
JM
,
Böhmker
F
,
Schuster
PU
,
Eberhardt
R
,
Gompelmann
D
,
Kontogianni
K
, et al
.
Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patients
.
Respir Med
.
2023
;
218
:
107399
.
30.
Perch
M
,
Titlestad
IL
,
Rychwicha-Kielek
BA
,
Bendstrup
E
,
Iversen
M
,
Siemsen
M
, et al
.
Bronchoscopic lung volume reduction is a treatment offered to patients with severe heterogenous emphysema
.
Ugeskr Laeger
.
2014
;
176
(
29
):
V01140005
.
31.
Valipour
A
,
Aisanov
Z
,
Avdeev
S
,
Koblizek
V
,
Kocan
I
,
Kopitovic
I
, et al
.
Recommendations for COPD management in central and eastern europe
.
Expert Rev Respir Med
.
2022
;
16
(
2
):
221
34
.
32.
Criner
GJ
,
Delage
A
,
Voelker
K
,
Hogarth
DK
,
Majid
A
,
Zgoda
M
, et al
.
Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial
.
Am J Respir Crit Care Med
.
2019
;
200
(
11
):
1354
62
.
33.
Franzen
D
,
Straub
G
,
Freitag
L
.
Complications after bronchoscopic lung volume reduction
.
J Thorac Dis
.
2018
;
10
(
Suppl 23
):
S2811
5
.
34.
Hartman
JE
,
Welling
JBA
,
Klooster
K
,
Carpaij
OA
,
Augustijn
SWS
,
Slebos
DJ
.
Survival in COPD patients treated with bronchoscopic lung volume reduction
.
Respir Med
.
2022
;
196
:
106825
.
35.
Roodenburg
SA
,
Klooster
K
,
Slebos
DJ
,
Hartman
JE
.
The impact of emphysema heterogeneity on treatment response after endobronchial valve treatment
.
ERJ Open Res
.
2023
;
9
(
4
):
00279
2023
.
You do not currently have access to this content.